BioWorld - Wednesday, April 30, 2025

Merger, BioWorld MedTech
Merger, BioWorld MedTech RSS Feed RSS

Elekta buys Icad’s brachytherapy business for $5.5M

Nov. 8, 2023
By Shani Alexander
The acquisition of Icad Inc.’s brachytherapy business by Elekta AB takes the company a step closer to achieving its goal of providing hope to the millions of people dealing with cancer, John Lapré, president of Elekta’s Brachy and Neuro Solutions unit, told BioWorld. Elekta paid approximately $5.5 million for Icad’s subsidiary Xoft. In addition, most of Xoft’s staff and its main facility in San José, Calif., was transferred to the company.
Read More
AI dollar sign

Ametek treats shareholders with $1.9B Paragon acquisition

Oct. 31, 2023
By Annette Boyle

There’s nothing scary for Ametek Inc. shareholders in the $1.9 billion acquisition of Paragon Medical Inc. announced on Oct. 31, 2023. The deal moves the industrial technology company solidly into the med-tech space as it picks up Paragon’s portfolio of products in orthopedics, minimally invasive surgery, robotic surgery and drug delivery, and adds an estimated $500 million per year in revenue and “very strong EPS accretion,” Ametek CEO David Zapico said in an investor call on Oct. 31.


Read More
MiroliverELAP - Miromatrix

United Therapeutics buying Miromatrix for up to $140M

Oct. 30, 2023
By Shani Alexander

United Therapeutics Corp. signed an agreement to acquire Miromatrix Medical Inc. for up to $140 million in cash, buying its way into additional organic growth. The deal would add Miromatrix’s comprehensive portfolio of bio-engineered organs to United’s existing organ production platform.


Read More
HypnoVR digital therapy

Hypnovr strengthens virtual therapy position with Oncomfort buy

Oct. 27, 2023
By Shani Alexander
Hypnovr SAS recent takeover of Oncomfort SA will bring digital therapeutic solutions to a larger patient population suffering from pain and anxiety. Oncomfort has developed Digital Sedation, a non-pharmacological method of relieving patients’ pain and anxiety. This therapy, coupled with Hypnovr’s own virtual reality (VR) solution will help reduce medication use and improve the care pathway for patients undergoing medical procedures.
Read More

Spinal market shows backbone for growth at NASS

Oct. 20, 2023
By Annette Boyle

The North American Spine Society Annual Meeting provided a positive view of one area in orthopedics that may be immune from the effects of widespread use of GLP-1 medications. Recent data indicates volumes and seasonality have finally recovered from pandemic impacts. Major trends discussed at the conference included expanded use of robotic systems, increased customization and adoption of augmented reality technology.


Read More
johnson & johnson

Johnson & Johnson puts orthopedics unit under the knife

Oct. 18, 2023
By Annette Boyle

Johnson & Johnson will excise less profitable lines and markets within its Depuy Synthes orthopedics business over the next two years, management revealed in its quarterly investor call on Oct. 16. Paring its products and related pursuits could cost as much as $800 million by the end of 2025, J&J Chief Financial Officer Joe Wolk said.


Read More
Olink

Thermo Fisher offers 75% premium in $3.1B bid for Olink

Oct. 17, 2023
By Annette Boyle
Olink Holding AB likely has some euphoric investors following Thermo Fisher Scientific Inc.’s announcement of an agreement to acquire the proteomics company for $26 per share in cash. The price represents a premium of nearly 75% on its recent trading average and brings the deal’s value to a stunning $3.1 billion, with net cash of $143 million.
Read More
Global currency

Getinge acquires Healthmark Industries for $320M

Oct. 13, 2023
By Shani Alexander
Getinge AB has acquired Healthmark Industries Co. Inc. for $320 million on a cash and debt basis in a bid to bolster its presence in sterile reprocessing in the U.S. The deal was financed using cash on hand and existing credit facilities. Getinge expects to fully integrate Healthmark’s operations by the end of 2024 and is not expected to see any material integration costs in 2023 and 2024.
Read More